At Novartis Argentina S.A., I submitted more than 2,000 ICSR and SUSAR safety cases per year, including Phase I–III clinical trial reports to ANMAT. These submissions achieved 99% on-time compliance with zero critical findings.
At GSK S.A. in 2026, I led medical review processes for scientific materials, with 200 materials approved per month. At AstraZeneca S.A., I handled safety reporting and medical information, including more than 200 medical inquiry cases per month.
I also led medical-literature safety signal detection at Novartis, contributing to the detection of 800 signals. I use Power Automate and AI agents to automate repetitive processes, and I’m currently completing the Clinical Research Monitor certification at FEFyM.
